99 related articles for article (PubMed ID: 21106616)
1. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration.
Wang N; Feng Y; Lau EP; Tsang C; Ching Y; Man K; Tong Y; Nagamatsu T; Su W; Tsao S
Integr Cancer Ther; 2010 Dec; 9(4):354-64. PubMed ID: 21106616
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
[TBL] [Abstract][Full Text] [Related]
3. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
[TBL] [Abstract][Full Text] [Related]
4. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS
J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165
[TBL] [Abstract][Full Text] [Related]
5. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
Laezza C; Pisanti S; Malfitano AM; Bifulco M
Endocr Relat Cancer; 2008 Dec; 15(4):965-74. PubMed ID: 18676619
[TBL] [Abstract][Full Text] [Related]
6. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
[TBL] [Abstract][Full Text] [Related]
7. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract][Full Text] [Related]
9. [Migration and invasion of human hepatocellular carcinoma mediated by lung extracts].
Ji XN; Ye SL; Li Y; Tian B; Chen J; Liu YK; Tang ZY
Ai Zheng; 2004 Jan; 23(1):23-7. PubMed ID: 14720369
[TBL] [Abstract][Full Text] [Related]
10. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma.
Genda T; Sakamoto M; Ichida T; Asakura H; Kojiro M; Narumiya S; Hirohashi S
Hepatology; 1999 Oct; 30(4):1027-36. PubMed ID: 10498656
[TBL] [Abstract][Full Text] [Related]
11. AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration.
Shih WL; Liao MH; Yu FL; Lin PY; Hsu HY; Chiu SJ
Cancer Lett; 2008 Nov; 270(2):202-17. PubMed ID: 18571835
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
[TBL] [Abstract][Full Text] [Related]
13. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway.
Liu S; Yu M; He Y; Xiao L; Wang F; Song C; Sun S; Ling C; Xu Z
Hepatology; 2008 Jun; 47(6):1964-73. PubMed ID: 18506888
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of recombinant human endostatin on the metastatic potential and invasiveness of hepatocellular carcinoma HCCLM6 cells in vitro].
Zhang PH; Qin J; Li AM; Ding XM; Yang-feng D; Rong-cheng L
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):658-61. PubMed ID: 18495614
[TBL] [Abstract][Full Text] [Related]
16. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target.
Lee TK; Man K; Ho JW; Wang XH; Poon RT; Sun CK; Ng KT; Ng IO; Xu R; Fan ST
Carcinogenesis; 2005 Mar; 26(3):681-7. PubMed ID: 15604094
[TBL] [Abstract][Full Text] [Related]
17. Neamine inhibits cell proliferation, migration, and invasion in H7402 human hepatoma cells.
Zhao J; Wang YC; Yang LY; Yu DH; Pan PT; Wang L
Saudi Med J; 2010 Dec; 31(12):1309-14. PubMed ID: 21135992
[TBL] [Abstract][Full Text] [Related]
18. Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation.
Serizawa N; Tian J; Fukada H; Baghy K; Scott F; Chen X; Kiss Z; Olson K; Hsu D; Liu FT; Török NJ; Zhao B; Jiang JX
Lab Invest; 2015 Oct; 95(10):1145-56. PubMed ID: 26146960
[TBL] [Abstract][Full Text] [Related]
19. [Effects of high metastatic potential hepatocellular carcinoma cell-binding peptide on the invasion and metastasis of liver cancer].
Jia WD; Wang W; Tang ZY; Xu GL; Sun HC; Zhou HJ
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):241-5. PubMed ID: 19615273
[TBL] [Abstract][Full Text] [Related]
20. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
